These patients also had salivary gland scintigraphy using technetium-99m, including a recording of the accumulation and secretion of radioactive labelled pertechnetate by the salivary glands, and gallium-67 citrate showing an increased uptake of gallium citrate if a cellular reactive process was present, possibly through lactoferrin as a gallium citrate binding protein in polymorphonuclear leucocytes.'6 Technetium99m scintigraphy (Tc scan) therefore represents the function of the major salivary glands, whereas gallium-67 citrate scintigraphy (Ga scan) indicates the activity of inflammation of the salivary glands. Quantification of salivary scintigraphy is difficult because of the anatomical site and shape of the glands, so all scans were scored blindly by an independent observer and two of the authors (AAK and RJH).
Safety and tolerability assessments included whole blood count, serum creatinine, alkaline phosp'atase, and transaminases every three months; ophthalmological examination was performed before the study, after one year, and after two years; if retinal changes were present the examination was repeated every three months.
STATISTICS
The effects of treatment with hydroxychloroquine and placebo in the two groups were analysed by comparing differences in outcome after the first and the second year between the two groups for continuous variables; only the results at the end of the two years were analysed because of possible carryover effects at earlier phases in a year. ' Results Nineteen patients, all women, took part in the study. Group HC-+plac, in which patients were treated with hydroxychloroquine in the first year and with placebo in the second year, consisted of 10 patients. Group plac-+HC, in which the order of treatment was reversed, consisted of nine patients.
In group HC-+plac the mean (SD) age was 52-8(16-1) years; in group plac-+HC it was 51 0(15-8) years. Median (range) disease duration in group HC-+plac was 2-5(0 1-15O0) years and in group plac-+HC 5 0(0 6-23O0) years (table 2) . Drugs used at the start of the trial are shown in table 3; these drugs were not changed during the course of the study.
Four patients did not complete the study, two in each group. In group HC-+plac one patient received corticosteroids because of pro- with respect to symptoms of dryness or sandy feelings of the eyes, inflammatory reaction of the eyes or eyelids, or symptoms of dryness of the mouth. No statistically significant differences were found for swelling of the salivary glands, fatigue, myalgia, nor arthralgia (table  4) . No significant period effect nor interaction between treatment and period was found for any of the outcome measures, although patients in the two groups tended to prefer the drug they used in the first year of the study.
IMMUNOSEROLOGY
Hydroxychloroquine and placebo treatment did not result in statistically significant differences for most of the laboratory parameters, except for -y globulin (p<0 05), IgM (p<0 005), and IgG (p<005) (table 5). Serum levels of these latter parameters were lower after treatment with hydroxychloroquine. The ESR was lower after treatment with hydroxychloroquine; the difference was, however, not statistically significant (p=0 07).
No change was seen in the qualitative tests for rheumatoid factor (in seven of the 14 patients rheumatoid factor was positive at entry and at the end of the study), antinuclear antibodies (7/14), nor in antibodies to double stranded DNA (0/14), SSA (10/14), and SSB (7/14). A period effect was found for the outcome measures ESR (p<005) and IgM (p<0 05), which decreased during the course of the study.
No statistically significant interaction between treatment and period could be detected for any of the laboratory outcome measures.
TEAR GLAND FUNCTION
No significant difference was found in tear gland activity nor in the sequelae of peripheral tear function deficiency (table 6) . No period effect or interaction effect between treatment and period was found for any of the tear gland function parameters.
SALIVARY SCINTIGRAPHY
In nine patients no major change was noticed in Tc nor Ga scintigraphy compared with initial scintigraphy. In one patient, however, increased activity on the initial Ga scan had not changed after the first year in which the patient was treated with placebo, but disappeared after the second year in which patient was treated with hydroxychloroquine, resulting in a normal Ga scan. A clinical decrease in swelling of the parotid glands was noticed in this patient. No change was seen in the Tc scan of this patient (table 7) .
SIDE EFFECTS
One patient developed a moderate deterioration of liver function tests at the end of the first year in which she appeared to have been treated with hydroxychloroquine. Alkaline phosphatase increased from 72 to 179 (normal (6) 27-1(14-9) 26 2(29-4) 26 7(32-2) 0-5(9 6) NS IgA (gll) HC-plac (8)
HC-plac (8) 24-1(3 0) 19-9(7-2) 22 5( 8 9 tStudent's t test. 
